IL10, interleukin 10, 3586

N. diseases: 1679; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005587
Disease: Depression, Bipolar
Depression, Bipolar
0.010 AlteredExpression disease BEFREE Interleukin (IL)-1β, tumor necrosis factor (TNF)-α, soluble TNF receptor (sTNFR)1, IL-12 and IL-10 were significantly higher in MDD than in BD, whereas IL-6, sTNFR2, IL-18, IL-33, ST2 (IL1R Like 1) and KLOTHO were significantly higher in BD than in MDD. 31693974 2020
CUI: C0005956
Disease: Bone Marrow Diseases
Bone Marrow Diseases
0.010 AlteredExpression group BEFREE Given that gut dysbiosis could augment the proinflammatory status of the intestines leading to a variety of acute inflammatory diseases, bone marrow-derived macrophages were stimulated with cecal content from dysbiotic mice showing a higher expression of proinflammatory cytokines and lower expression of IL-10. 31682032 2020
CUI: C0152021
Disease: Congenital heart disease
Congenital heart disease
0.010 Biomarker group BEFREE The importance of the anti-inflammatory mediators IL-1ra and IL-10, as well as cytokines Epo and VEGF, which could impact on the pathogenesis and outcomes in congenital heart disease (CHD) which is more prevalent in DS, are less well known. 31785499 2020
CUI: C0162323
Disease: Polyarthritis
Polyarthritis
0.010 Biomarker disease BEFREE RSVO also prevented polyarthritis-related cartilage destruction, an effect that might rely on the inhibition of the pro-inflammatory cytokine interleukin-6 (IL-6), associated with an increase of the anti-inflammatory cytokine interleukin-10 (IL-10). 31720991 2020
CUI: C0234245
Disease: Visceral Pain
Visceral Pain
0.010 Biomarker phenotype BEFREE Endogenous control of visceral pain by opioids locally produced in inflamed mucosa was assessed in IL-10-deficient mice. 31588671 2020
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders
0.010 AlteredExpression group BEFREE Elevated levels of pro-inflammatory RANTES or MCP-1 and decreased levels of anti-inflammatory IL-10 were found to associate with Parkinsonism and a more rapid disease progression, indicated by longitudinal measurements of either MMSE or ADCS-ADL decline. 31559531 2020
CUI: C0343804
Disease: Chronic Chagas' disease
Chronic Chagas' disease
0.010 Biomarker disease BEFREE Serum IL-10 Levels and Its Relationship with Parasitemia in Chronic Chagas Disease Patients. 31701864 2020
CUI: C0751057
Disease: Seizure, Febrile, Complex
Seizure, Febrile, Complex
0.010 AlteredExpression disease BEFREE Cerebrospinal fluid levels of granzyme A were significantly higher, and those of TNF-α and IL-1RA were significantly lower in the AE group than in the cFS group; however, no significant differences in the levels of granzyme B, IFN-γ, IL-1β, IL-4, IL-6, IL-8, and IL-10 were observed between the 2 groups. 31709864 2020
Recurrent respiratory papillomatosis
0.010 Biomarker disease BEFREE Plasma IL-10 as well as IL-10 secreted by mDC was higher in JORRP patients compared with healthy control. 31726188 2020
CUI: C1306068
Disease: After-cataract
After-cataract
0.010 Biomarker disease BEFREE In alcohol-fed mice, infiltrating CD11b<sup>+</sup> Ly-6C<sup>Low/-</sup> monocytes had reduced mRNA expression of matrix metalloproteinase 13 and matrix metalloproteinase 9 and increased expression of tissue inhibitor of matrix metalloproteinase 1, Tgfb1, and interleukin-10 during resolution of CF. 31206736 2020
CUI: C1306587
Disease: Acute encephalopathy
Acute encephalopathy
0.010 AlteredExpression disease BEFREE Cerebrospinal fluid levels of granzyme A were significantly higher, and those of TNF-α and IL-1RA were significantly lower in the AE group than in the cFS group; however, no significant differences in the levels of granzyme B, IFN-γ, IL-1β, IL-4, IL-6, IL-8, and IL-10 were observed between the 2 groups. 31709864 2020
CUI: C1535950
Disease: Gastrointestinal inflammation
Gastrointestinal inflammation
0.010 Biomarker disease BEFREE IL-10 is an immune regulatory cytokine and its genetic defect leads to gastrointestinal inflammation in both human and mouse. 31755523 2020
CUI: C0003165
Disease: Anthracosis
Anthracosis
0.010 Biomarker disease BEFREE HBV: hepatitis B virus; HCC hepatocellular carcinoma; TNFSF10: tumor necrosis factor superfamily member 10; ATG5: autophagy-related protein 5; DNA: deoxyribonucleic acid; LDR-PCR: ligase detection reactions-polymerase chain reaction; PCR: polymerase chain reaction; SLE: systemic lupus erythematosus; BD: Behçet's disease; IL-10: interlukin-10; LPS: lipopolysaccharide; PBMC: peripheral blood mononuclear cells; CWP: coal workers' pneumoconiosis; TNF-α: tumor necrosis factor-α. 30907204 2019
CUI: C0006267
Disease: Bronchiectasis
Bronchiectasis
0.010 AlteredExpression disease BEFREE Furthermore, remarkable increased level of IL17 and IL-6 and decreased level of IL-10 and TGF-ß were observed in the bronchiectasis combined COPD than in pure COPD (All P<0.05). 31503552 2019
CUI: C0006430
Disease: Burning Mouth Syndrome
Burning Mouth Syndrome
0.010 AlteredExpression disease BEFREE IL-10 levels were measured in three studies that reported no significant differences in the levels between Burning Mouth Syndrome and healthy controls. 31132870 2019
CUI: C0008495
Disease: Chorioamnionitis
Chorioamnionitis
0.010 AlteredExpression phenotype BEFREE TLR2 and TLR4-mediated TNF-α, IL-1β, IL-6, IL-12p70, and IL-10 production in vitro increased over the first month of life in preterm infants and were positively correlated with leukocyte-adjusted cAMP levels and reduced by exposure to chorioamnionitis. 31578034 2019
CUI: C0010246
Disease: Coxsackievirus Infections
Coxsackievirus Infections
0.010 Biomarker group BEFREE IL-10-producing B cells attenuate cardiac inflammation by regulating Th1 and Th17 cells in acute viral myocarditis induced by coxsackie virus B3. 31493482 2019
CUI: C0011882
Disease: Diabetic Neuropathies
Diabetic Neuropathies
0.010 GeneticVariation group BEFREE Our study assessed the association between ACE I>D, MTHFR C677T, MTHFR 1298A/C, GPx-1 rs1050450, CAT -262C/T, GSTM1, GSTT1, and IL-10 -1082G/A polymorphisms and DN risk. 31557408 2019
CUI: C0012754
Disease: Distemper
Distemper
0.010 AlteredExpression disease BEFREE IL-10 mRNA expression was dramatically enhanced at 12-36 h after CDV infection. 30999020 2019
CUI: C0013238
Disease: Dry Eye Syndromes
Dry Eye Syndromes
0.010 Biomarker disease BEFREE Compared with healthy controls, interleukin-6 was significantly higher (<i>p</i> = 0.0001) in patients with primary open-angle glaucoma and interleukin-1β (<i>p</i> = 0.0144), interleukin-6 (<i>p</i> < 0.0001), and interleukin-10 (<i>p</i> = 0.0392) were higher in patients with dry eye disease. 30175615 2019
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.010 AlteredExpression disease BEFREE The results of total IgG, IgG1, IgG2a levels and secretion of IFN-γ, IL-4 and IL-10 revealed that immune responses were enhanced when the epitope recombinant vaccine of FMD virus coupled with IL-2 and FcIgG. 31004723 2019
CUI: C0016382
Disease: Flushing
Flushing
0.010 AlteredExpression phenotype BEFREE Interferon-stimulated genes (ISGs: ISG15 and OAS1) were increased in both PMNs and PBMCs, with up-regulation of PTGES and anti-inflammatory cytokines (TGFB1 and IL10) expressions at Day-7 of post-inseminations in cows, when compared to those at Day-7 in non-inseminated cows. 30376193 2019
CUI: C0016782
Disease: Fuchs' heterochromic cyclitis
Fuchs' heterochromic cyclitis
0.010 AlteredExpression disease BEFREE We observed a significant decrease in IL-10 levels in the AqH of patients with BU and a significant increase in VEGF levels in the AqH of patients with FUS compared to controls. 31065903 2019
CUI: C0020452
Disease: Hyperemia
Hyperemia
0.010 Biomarker disease BEFREE To characterize the preclinical model the parameters more used include body weight, stool consistency and morbidity, inflammatory biomarkers like interferon (IFN)-γ, myeloperoxidase (MPO), tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10, presence of ulcers, thickness or hyperemia in the colon, and histological evaluation of the inflammation. 31581545 2019
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.010 Biomarker disease BEFREE When combined with HI + IL-10 or IL-10 alone it decreased also significantly hAC proliferation compared to NG<sub>w/o</sub>. 30759730 2019